Cephalalgia

1. DRUMMOND PD, Finch PM
   Therapeutic dissociation of CGRP-targeted treatments in migraine and complex regional pain syndrome: Authors' reply.
   Cephalalgia. 2026;46:3331024261430856.
   

   >> Share

   
   

   
   Headache

2. BENKLI B
   Editorial: Migraine as a marker of maternal morbidity.
   Headache. 2026 Mar 20. doi: 10.1111/head.70090.
   

   >> Share

   
   
3. SJONNESEN K, Noel M, Pringsheim T, Patten SB, et al
   Maternal and child mental health and incident migraine in adolescence: An "All Our Families" prospective cohort study.
   Headache. 2026 Mar 19. doi: 10.1111/head.70078.
   

   >> Share

   
   
4. BERGER CT, Villena FB, Vogt SB, Heydrich L, et al
   Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine.
   Headache. 2026 Mar 15. doi: 10.1111/head.70082.
   

   >> Share

   
   
5. TRAM MT, Cheng N, Jicha C
   Differential impact of migraine on severe maternal morbidity and postpartum readmissions: Insights from a national cohort study.
   Headache. 2026 Mar 13. doi: 10.1111/head.70080.
   

   >> Share

   
   
6. CAO B, Chen Q, Liu Y, Wu R, et al
   Microneedles for the treatment of migraine and orofacial pain: A narrative review.
   Headache. 2026 Mar 13. doi: 10.1111/head.70074.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

7. ROMOZZI M, Di Nardo L, Iannone LF, Cuffaro G, et al
   PACAP-38 is increased in the tear fluid of patients with migraine.
   J Neurol Neurosurg Psychiatry. 2026 Mar 18:jnnp-2025-337981.
   

   >> Share

   
   

   
   PLoS One

8. CHOI SY, Oh SY, Kim HA, Park JY, et al
   Therapeutic efficacy of nimodipine and topiramate on migraine and vestibular migraine; A prospective multicenter open-label study.
   PLoS One. 2026;21:e0344948.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share